HarbourVest Partners LLC
An institutional investment manager in Boston, MA. Its Form 13F for the quarter ended Jun 30, 2026, filed Aug 14, 2026. SEC CIK 1201001.
- Reported value$170.0m
- Positions6
Holdings: 6 positions
The filing on sec.govAs filed, largest first. Reported value is what the manager stated for each position at the quarter end, in US dollars; it is filing data, not a price. Weight is the position's share of the total reported value. Changes compare with the 13F for the quarter ended 2026-03-31.
| Issuer | Class | CUSIP | Reported value$m | Weight | Shares | Put or call | Change on the quarter before |
|---|---|---|---|---|---|---|---|
| Klarna Group PLC | SHS | G5279N105 | 102 | 59.8% | 5,023,320 | Unchanged | |
| Generate BiomedicinesGENB | COM SHS | 370920100 | 29.1 | 17.1% | 1,722,210 | Unchanged | |
| Xanadu Quantum Technologies, IncXNDU | SUB VTG B | 98390R102 | 25.9 | 15.2% | 2,140,000 | New+2,140,000 | |
| Full Truck Alliance Co. Ltd.YMM | Sponsored ADS | 35969L108 | 7.8 | 4.6% | 957,580 | Unchanged | |
| CAMP4 Therapeutics CorpCAMP | Common | 13463J101 | 5.6 | 3.3% | 1,271,948 | Unchanged | |
| Century Therapeutics, Inc.IPSC | Common | 15673T100 | 0.1 | <0.1% | 29,018 | Unchanged |
Source: SEC EDGAR, Form 13F-HR, accession 0001193125-26-350253 (on sec.gov). Last ingested by Listed: Oct 22, 2026, 05:26 ET. Listed shows no prices and gives no investment advice.